H1B Salary Data

Home › Employers › Myriad Women's Health, Inc.

Myriad Women's Health, Inc.: H-1B salaries and sponsorship

Myriad Women's Health, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $165,000.

Applications (LCAs)3
Certified3
Employer addressSouth San Francisco, CA
H-1B dependent employerNo
Median offered salary$165,000
Middle half of salaries$165,000–$196,830
10th–90th percentile$165,000–$215,928

Does Myriad Women's Health, Inc. sponsor H-1B visas?

Myriad Women's Health, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Mar 20, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Senior Supply Chain Manager2$165,000
Senior Bioinformatics Scientist1$228,660

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20232$165,000
FY20251$228,660

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Senior Bioinformatics Scientist$228,660
Level IV
South San Francisco, CAMar 20, 2025Sep 6, 2025Certified
Senior Supply Chain Manager$165,000
Level IV
South San Francisco, CAMay 11, 2023Oct 1, 2023Certified
Senior Supply Chain Manager$165,000
Level IV
South San Francisco, CAApr 12, 2023Oct 1, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).